Endocrinology Flashcards
Rapid acting insulins
Insulin (short acting)
Lispro
Aspart
Glulisine
Intermediate acting insulin
NPH
Long acting insulin
Glargine
Detemir
Biguanides: Metformin
- bypass insulin receptors
- Mech: activates PPAR
- Use: 1st line therapy for DM2
- Tox: GI upset, lactic acidosis (C/I in renal failure)
Sulfonylureas: First generation
Tolbutamide
Chlorpropamide
- Stimulates insulin release
- Mech: Close K+ channel in β-cell membrane => cell depolarizes & triggers insulin release via Ca2+ influx.
- Use: DM2, useless in DM1.
- Tox: Hypoglycemia in renal failure, disulfiram-like effects.
Sulfonylureas: Second generation:
Glyburide
Glimepiride
Glipizide
- Stimulates insulin release
- Mech: Close K+ channel in β-cell membrane => cell depolarizes & triggers insulin release via Ca2+ influx.
- Use: DM2, useless in DM1.
- Tox: Hypoglycemia.
Glitazones/thiazolidinediones:
Pioglitazone
Rosiglitazone
- bypass insulin receptors
- Mech: activates PPAR
- Use: DM2
- Tox: Weight gain, edema, hepatotoxicity, heart failure.
α-glucosidase inhibitors:
Acarbose
Miglitol
- dec. postprandial hyperglycemia.
- Use: DM2
- Tox: GI disturbance
Amylin analogs:
Pramlintide
- dec. gastric emptying, dec. glucagon.
- Use: DM1 & 2
- Tox: Hypoglycemia, nausea, diarrhea.
GLP-1 analogs:
Exenatide
Liraglutide
- inc. insulin prod.
- Mech: stimulating beta-cells to prod. insulin
- Use: DM2
- Tox: Nausea, vomiting, pancreatitis.
DPP-4 inhibitors:
Linagliptin
Saxagliptin
Sitagliptin
- inc. insulin prod.
- Mech: inhibiting DPP-4 from digesting GLP-1
- Use: DM2
- Tox: Mild urinary or respiratory infections.
Sulfonylureas: First generation
Tolbutamide
Chlorpropamide
Sulfonylureas: Second generation:
Glyburide
Glimepiride
Glipizide
Glitazones/thiazolidinediones:
Pioglitazone
Rosiglitazone
α-glucosidase inhibitors:
Acarbose
Miglitol